Ocera Therapeutics, Inc. (NASDAQ:OCRX) is a clinical stage biopharmaceutical company focused on the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease.

Investors 1

Mentions in press and media 2

DateTitleDescriptionCategoryAuthorSource
03.08.2015Daily fund...Snapdeal raised $500M; Drivewa...-Mitos Suso...vator.tv/n...
03.08.2015Ocera Ther...Ocera Therapeutics, Inc. (NASD...USA-finsmes.co...